Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Covington
AstraZeneca
Chinese Patent Office
Accenture
McKesson
Colorcon
Argus Health
Harvard Business School
Express Scripts

Generated: February 24, 2018

DrugPatentWatch Database Preview

UREAPHIL Drug Profile

« Back to Dashboard

Which patents cover Ureaphil, and when can generic versions of Ureaphil launch?

Ureaphil is a drug marketed by Hospira and is included in one NDA.

The generic ingredient in UREAPHIL is urea. There are thirty-three drug master file entries for this compound. Additional details are available on the urea profile page.

US Patents and Regulatory Information for UREAPHIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira UREAPHIL urea INJECTABLE;INJECTION 012154-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Covington
Chubb
Harvard Business School
Baxter
UBS
Fuji
Mallinckrodt
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot